Therefore, potential therapeutic interventions directed at these cells in CF and other diseases would have to be carefully calibrated to recover defective bacterial killing and limit the effects of extracellular elastase and MPO, while preserving the beneficial functions of these tissue-recruited neutrophils. Here, MPO is linked to cystic fibrosis.